Covid-19: 'India not an experiment lab for vaccine', says Digvijaya Singh

Video Credit: HT Digital Content
Published on December 8, 2020 - Duration: 02:35s

Covid-19: 'India not an experiment lab for vaccine', says Digvijaya Singh

Congress leader Digvijaya Singh said that India shouldn't be made an experiment lab.

Singh said that people of India should not be made guinea pigs for vaccine trials.

"Protocols can still be compromised during the pandemic.

People of India should not be made guinea pigs.

Haryana minister Anil Vij got vaccinated and later tested positive.

Before human trials, animal trials are done to launch a vaccine.

India cannot be an experiment lab for any vaccine," he said.

Bharat Biotech, SII, and Pfizer recently asked for emergency use approval in India.

At least eight different vaccine candidates are at different trial stages in India.

PM Modi had recently held meeting and visited vaccine labs in the country.

He had discussed Covid vaccination plan during an all-party meeting held earlier.


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions








Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery..
Credit: IndiaTimes - Published 2 days ago

Related videos from verified sources

Covid new strain: How India is preparing to tackle UK & variants of virus 07:51
Video credit: HT Digital Content - Published on December 29, 2020 

Multiple modes of transportation will be used to distribute COVID vaccine: Govt 02:18
Video credit: ANI - Published on December 29, 2020 

Watch: Dry run of Covid vaccination at Punjab's Shaheed Bhagat Singh Nagar 01:45
Video credit: HT Digital Content - Published on December 29, 2020 

You might like